"Designing Growth Strategies is in our DNA"

Fibromyalgia Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Antidepressants, Antiepileptic, Muscle Relaxants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI105016

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Fibromyalgia by key Regions
    2. Key Industry Trends
    3. Pipeline Analysis
    4. Regulatory Scenario
    5. Recent Industry Developments Such as Mergers & Acquisitions
    6. Impact of COVID-19 on the Market
  5. Global Fibromyalgia Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Antidepressants
      2. Antiepileptic
      3. Muscle Relaxants
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Fibromyalgia Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Antidepressants
      2. Antiepileptic
      3. Muscle Relaxants
      4. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis – By Country
      1. U.S.
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      2. Canada
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
  7. Europe Fibromyalgia Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Antidepressants
      2. Antiepileptic
      3. Muscle Relaxants
      4. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis – By Country
      1. U.K.
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      2. Germany
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      3. France
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      4. Spain
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      5. Italy
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      6. Scandinavia
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      7. Rest of Europe
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
  8. Asia Pacific Fibromyalgia Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Antidepressants
      2. Antiepileptic
      3. Muscle Relaxants
      4. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis – By Country
      1. Japan
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      2. China
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      3. India
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      4. Australia
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      5. Southeast Asia
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      6. Rest of Asia Pacific
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
  9. Latin America Fibromyalgia Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Antidepressants
      2. Antiepileptic
      3. Muscle Relaxants
      4. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis – By Country
      1. Brazil
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      2. Mexico
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      3. Rest of Latin America
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
  10. Middle East & Africa Fibromyalgia Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Antidepressants
      2. Antiepileptic
      3. Muscle Relaxants
      4. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis – By Country
      1. GCC
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      2. South Africa
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
      3. Rest of Middle East & Africa
        1. By Drug Class
          1. Antidepressants
          2. Antiepileptic
          3. Muscle Relaxants
          4. Others
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Pfizer, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Eli Lilly and Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Allegran
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Tonix Pharmaceuticals
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Aptinyx
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Sun Pharmaceuticals
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Astella Pharma Inc
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Fibromyalgia Treatment Market Revenue Breakdown (USD Million, %) by Region, 2019 & 2027

Figure 2:  Global Fibromyalgia Treatment Market Value Share (%), by Drug Class, 2019 & 2027

Figure 3:  Global Fibromyalgia Treatment Market Forecast (USD Million), by Antidepressants, 2016-2027

Figure 4:  Global Fibromyalgia Treatment Market Forecast (USD Million), by Antiepileptic, 2016-2027

Figure 5:  Global Fibromyalgia Treatment Market Forecast (USD Million), by Muscle Relaxants, 2016-2027

Figure 6:  Global Fibromyalgia Treatment Market Forecast (USD Million), by Others, 2016-2027

Figure 7:  Global Fibromyalgia Treatment Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 8:  Global Fibromyalgia Treatment Market Forecast (USD Million), by Hospital Pharmacy, 2016-2027

Figure 9:  Global Fibromyalgia Treatment Market Forecast (USD Million), by Retail Pharmacy, 2016-2027

Figure 10:  Global Fibromyalgia Treatment Market Forecast (USD Million), by Online Pharmacy, 2016-2027

Figure 11:  Global Fibromyalgia Treatment Market Value (USD Million), by Region, 2019 & 2027

Figure 12:  North America Fibromyalgia Treatment Market Value (USD Million), by Drug Class, 2019 & 2027

Figure 13:  North America Fibromyalgia Treatment Market Value Share (%), by Drug Class, 2019

Figure 14:  North America Fibromyalgia Treatment Market Value (USD Million), by Distribution Channel, 2019 & 2027

Figure 15:  North America Fibromyalgia Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 16:  North America Fibromyalgia Treatment Market Value (USD Million), By Country, 2019 & 2027

Figure 17:  North America Fibromyalgia Treatment Market Value Share (%), By Country, 2019

Figure 18:  Europe Fibromyalgia Treatment Market Value (USD Million), by Drug Class, 2019 & 2027

Figure 19:  Europe Fibromyalgia Treatment Market Value Share (%), by Drug Class, 2019

Figure 20:  Europe Fibromyalgia Treatment Market Value (USD Million), by Distribution Channel, 2019 & 2027

Figure 21:  Europe Fibromyalgia Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 22:  Europe Fibromyalgia Treatment Market Value (USD Million), By Country/ Sub-region, 2019 & 2027

Figure 23:  Europe Fibromyalgia Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 24:  Asia Pacific Fibromyalgia Treatment Market Value (USD Million), by Drug Class, 2019 & 2027

Figure 25:  Asia Pacific Fibromyalgia Treatment Market Value Share (%), by Drug Class, 2019

Figure 26:  Asia Pacific Fibromyalgia Treatment Market Value (USD Million), by Distribution Channel, 2019 & 2027

Figure 27:  Asia Pacific Fibromyalgia Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 28:  Asia Pacific Fibromyalgia Treatment Market Value (USD Million), By Country/ Sub-region, 2019 & 2027

Figure 29:  Asia Pacific Fibromyalgia Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 30:  Latin America Fibromyalgia Treatment Market Value (USD Million), by Drug Class, 2019 & 2027

Figure 31:  Latin America Fibromyalgia Treatment Market Value Share (%), by Drug Class, 2019

Figure 32:  Latin America Fibromyalgia Treatment Market Value (USD Million), by Distribution Channel, 2019 & 2027

Figure 33:  Latin America Fibromyalgia Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 34:  Latin America Fibromyalgia Treatment Market Value (USD Million), By Country/ Sub-region, 2019 & 2027

Figure 35:  Latin America Fibromyalgia Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 36:  Middle East & Africa Fibromyalgia Treatment Market Value (USD Million), by Drug Class, 2019 & 2027

Figure 37:  Middle East & Africa Fibromyalgia Treatment Market Value Share (%), by Drug Class, 2019

Figure 38:  Middle East & Africa Fibromyalgia Treatment Market Value (USD Million), by Distribution Channel, 2019 & 2027

Figure 39:  Middle East & Africa Fibromyalgia Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 40:  Middle East & Africa Fibromyalgia Treatment Market Value (USD Million), By Country/ Sub-region, 2019 & 2027

Figure 41:  Middle East & Africa Fibromyalgia Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 42:  Global Fibromyalgia Treatment Market Share (%), By Company, 2019

Table 1:  Global Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Drug Class, 2016–2027

Table 2:  Global Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016–2027

Table 3:  Global Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Region, 2016-2027

Table 4:  North America Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Drug Class, 2016-2027

Table 5:  North America Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016-2027

Table 6:  North America Fibromyalgia Treatment Market Revenue (USD Million) Forecast, By Country, 2016-2027

Table 7:  Europe Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Drug Class, 2016-2027

Table 8:  Europe Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016-2027

Table 9:  Europe Fibromyalgia Treatment Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2016-2027

Table 10:  Asia Pacific Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Drug Class, 2016-2027

Table 11:  Asia Pacific Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016-2027

Table 12:  Asia Pacific Fibromyalgia Treatment Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2016-2027

Table 13:  Latin America Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Drug Class, 2016-2027

Table 14:  Latin America Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016-2027

Table 15:  Latin America Fibromyalgia Treatment Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Middle East & Africa Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Drug Class, 2016-2027

Table 17:  Middle East & Africa Fibromyalgia Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016-2027

Table 18:  Middle East & Africa Fibromyalgia Treatment Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2016-2027

Fibromyalgia Treatment Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase